US Edition
Muscular Dystrophy: Experimental Stem Cell Therapy Generates New Heart Tissue – Patient Worthy
Summary by Patient Worthy
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Muscular Dystrophy: Experimental Stem Cell Therapy Generates New Heart Tissue – Patient Worthy
The FDA recently informed Muscular Dystrophy News that it has granted orphan drug designation to the experimental drug ISX9-CPC, a product of the IPS Heart company located in Houston, Texas. The designation awarded to the experimental drug is an incentive to accelerate the creation of treatments for rare diseases that affect under 200,000 people in […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
